Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (91-100 of 785) with videos related to

Pageof 79
Sort By:
The New England Journal of Medicine|March 11, 2016
Soluble Urokinase Receptor and Chronic Kidney DiseaseMartin Schumacher, Christoph Wanner, Jan Beyersmann
Lancet (London, England)|May 27, 2016
The heart and vascular system in dialysisChristoph Wanner, Kerstin Amann, Tetsuo Shoji
Deutsche Medizinische Wochenschrift (1946)|November 22, 2019
[Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)]Uwe Zeymer, Hendrik Bonnemeier, Christoph Wanner
Kidney & Blood Pressure Research|November 25, 2006
Effects of pravastatin treatment on blood pressure regulation after renal transplantationKai Lopau, Katrin Spindler, Christoph Wanner
Clinical Kidney Journal|March 3, 2023
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal AssociationAlberto Ortiz, Christoph Wanner, Ron Gansevoort, et al.
Circulation|October 26, 2018
Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"Christoph Wanner, Maximilian von Eynatten, Bernard Zinman
Future Cardiology|September 8, 2022
Plain language summary of a study looking at heart muscle thickness and kidney function in women with Fabry disease who received agalsidase beta treatmentChristoph Wanner, Ulla Feldt-Rasmussen, Alberto Ortiz
Deutsche Medizinische Wochenschrift (1946)|August 4, 2023
[Renal insufficiency and cardiovascular risk]Christoph Wanner, Anna Laura Herzog, Jule Pinter
Journal of Hypertension|September 1, 2017
Sympathomodulatory effects of sodium-glucose transporter-2 inhibitors in the kidneys and beyondPeter J Blankestijn, Christoph Wanner, Guido Grassi
ESC Heart Failure|August 4, 2017
A Janus-headed electrolyte and 'RALES' disease'Daniel Kraus, Christoph Wanner, Bettina J Kraus
Pageof 79

Showing results (91-100 of 785) with videos related to

Sort By:
Pageof 79
The New England Journal of Medicine|March 11, 2016
Soluble Urokinase Receptor and Chronic Kidney DiseaseMartin Schumacher, Christoph Wanner, Jan Beyersmann
Lancet (London, England)|May 27, 2016
The heart and vascular system in dialysisChristoph Wanner, Kerstin Amann, Tetsuo Shoji
Deutsche Medizinische Wochenschrift (1946)|November 22, 2019
[Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)]Uwe Zeymer, Hendrik Bonnemeier, Christoph Wanner
Kidney & Blood Pressure Research|November 25, 2006
Effects of pravastatin treatment on blood pressure regulation after renal transplantationKai Lopau, Katrin Spindler, Christoph Wanner
Clinical Kidney Journal|March 3, 2023
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal AssociationAlberto Ortiz, Christoph Wanner, Ron Gansevoort, et al.
Circulation|October 26, 2018
Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"Christoph Wanner, Maximilian von Eynatten, Bernard Zinman
Future Cardiology|September 8, 2022
Plain language summary of a study looking at heart muscle thickness and kidney function in women with Fabry disease who received agalsidase beta treatmentChristoph Wanner, Ulla Feldt-Rasmussen, Alberto Ortiz
Deutsche Medizinische Wochenschrift (1946)|August 4, 2023
[Renal insufficiency and cardiovascular risk]Christoph Wanner, Anna Laura Herzog, Jule Pinter
Journal of Hypertension|September 1, 2017
Sympathomodulatory effects of sodium-glucose transporter-2 inhibitors in the kidneys and beyondPeter J Blankestijn, Christoph Wanner, Guido Grassi
ESC Heart Failure|August 4, 2017
A Janus-headed electrolyte and 'RALES' disease'Daniel Kraus, Christoph Wanner, Bettina J Kraus
Pageof 79